China Dasheng Biotechnology Company
CDBT · OTC
6/30/2023 | 6/30/2022 | 6/30/2008 | 10/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $0 | – | $0 | -$0 |
| % Margin | – | – | 46.1% | – |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $0 | – | $0 | $0 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $0 | – | $0 | $0 |
| Operating Income | -$0 | – | $0 | -$0 |
| % Margin | – | – | 31.1% | – |
| Other Income/Exp. Net | -$0 | – | $0 | $0 |
| Pre-Tax Income | -$0 | – | $0 | -$0 |
| Tax Expense | $0 | – | $0 | $0 |
| Net Income | -$0 | – | $0 | -$0 |
| % Margin | – | – | 28.5% | – |
| EPS | -0.024 | – | 0.15 | -0.01 |
| % Growth | – | – | 1,600% | – |
| EPS Diluted | -0.024 | – | 0.15 | -0.01 |
| Weighted Avg Shares Out | 0 | – | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | – | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $0 | $0 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | -$0 | – | $0 | -$0 |
| % Margin | – | – | 35% | – |